Image (47d4a758 E84f 479d Affa B6a666c70173 01)
Ambrisentan Tablet, Film Coated
Product Images NDC 82009-142
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Ambrisentan (NDC 82009-142). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (47d4a758 E84f 479d Affa B6a666c70173 02)
This is a list of interacting drugs including Cyclosporine, Mycophenolate Mofetil, Ketoconazale, Omeprazole, Rifampin, Ritonavir, Sildenafil, Tacrolimus, Tadalafil, and Warfarin. The text provides recommendations for dose adjustments when combined with Ambrisentan. It suggests limiting Ambrisentan to 5 mg once daily and indicates no dose adjustments needed for the other drugs listed.*
Image (47d4a758 E84f 479d Affa B6a666c70173 03)
This is a list of interacting drugs and their impact on various pharmacokinetic parameters like Cmax and AUC. It also includes recommendations for dose adjustments based on the interactions observed. The list covers drugs such as Cyclosporine, Digoxin, Ethinylestradiol, Norethindrone, Mycophenolic acid, Ritonavir, Sildenafil, Tadalafil, Warfarin, and provides recommendations for each based on the observed interactions.*
Image (47d4a758 E84f 479d Affa B6a666c70173 04)
This is a comparison between two groups, ARIES-1 and ARIES-2, over a 12-week period based on meters covered at Weeks 4, 8, and 12. The text indicates that there is a placebo group included in ARIES-2.*
Image (47d4a758 E84f 479d Affa B6a666c70173 05)
Image (47d4a758 E84f 479d Affa B6a666c70173 06)
5 mg (47d4a758 E84f 479d Affa B6a666c70173 07)
This text provides information about a package of 30 tablets, each containing 5 mg of Ambrisentan. The instructions indicate that the tablets are film-coated and should not be split, crushed, or chewed. It advises storing the tablets at a temperature between 20°C to 25°C (68°F to 77°F). The package is child-resistant and should be kept tightly closed. Additionally, it mentions the availability of a Medication Guide at quallentpharmaceuticals.com or by calling 1-877-605-7243. The tablets are manufactured by Zydus Lifesciences Ltd in Ahmedabad, India, for Quallent Pharmaceuticals in Grand Cayman, Cayman Islands.*
10 mg (47d4a758 E84f 479d Affa B6a666c70173 08)
These tablets contain Ambrisentan, 10 mg, and come in a package that is child-resistant. It is important not to spill, crush, or chew the tablets. The recommended storage temperature is between 20°C to 25°C (68 to 77°F). The medication guide is available at quallentpharmaceuticals.com, or you may call 1-677-605-7243 for more information about this prescription drug. The tablets are manufactured by Zydus Lifesciences Ltd in Ahmedabad, India, and distributed by Quallent Pharmaceuticals Health LLC in the Grand Cayman, Cayman Islands.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
